THE EFFECTS OF A 5-LIPOXYGENASE INHIBITOR, BW A4C, ON THE ACUTE RESPONSE TO INHALED PAF IN MAN

被引：0
|
作者：
SPENCER, DA
SAMPSON, AP
EVANS, JM
GARLAND, LG
PIPER, PJ
COSTELLO, JF
机构：
[1] UNIV LONDON KINGS COLL HOSP, DEPT THORAC MED, LONDON SE5 8RX, ENGLAND
[2] ROYAL COLL SURG ENGLAND, DEPT PHARMACOL, LONDON WC2, ENGLAND
[3] WELLCOME RES LABS, BECKENHAM BR3 3BS, KENT, ENGLAND
来源：
ANNALS OF THE NEW YORK ACADEMY OF SCIENCES | 1991年 / 629卷
关键词：
D O I：
暂无
中图分类号：
O [数理科学和化学]; P [天文学、地球科学]; Q [生物科学]; N [自然科学总论];
学科分类号：
07 ; 0710 ; 09 ;
摘要：
引用
收藏
页码：430 / 431
页数：2
相关论文
共 50 条
  • [1] SELECTIVE 5-LIPOXYGENASE INHIBITOR BW A4C DOES NOT INFLUENCE PROGRESSION OF TISSUE-INJURY IN A CANINE MODEL OF REGIONAL MYOCARDIAL-ISCHEMIA AND REPERFUSION
    MAXWELL, MP
    MARSTON, C
    HADLEY, MR
    SALMON, JA
    GARLAND, LG
    JOURNAL OF CARDIOVASCULAR PHARMACOLOGY, 1991, 17 (04) : 539 - 545
  • [2] Potent dual 5-lipoxygenase inhibitor and PAF receptor antagonist
    Lloyd, AW
    DRUG DISCOVERY TODAY, 1998, 3 (09) : 424 - 424
  • [3] Effects of dual inhibitor of cyclooxygenase and 5-lipoxygenase on acute necrotizing pancreatitis in rats
    Kalyoncu, Nuri I.
    Alhan, Etem
    Ercin, Cengiz
    Kural, Birgul Vanizor
    HEPATO-GASTROENTEROLOGY, 2006, 53 (70) : 597 - 602
  • [4] EFFECTS IN MAN OF SC-45662, A 5-LIPOXYGENASE INHIBITOR (5-LOI), AFTER ACUTE NASAL ALLERGEN CHALLENGE
    ALEXANDER, J
    KEANE, B
    METCALF, LE
    MORAN, M
    OBRYANTEAR, G
    KNAPP, HR
    MURRAY, JJ
    JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 1992, 89 (01) : 208 - 208
  • [5] Effects of 5-lipoxygenase inhibitor zileuton on airway responses to inhaled swine house dust in healthy subjects
    Larsson, BM
    Kumlin, M
    Sundblad, BM
    Larsson, K
    Dahlén, SE
    Palmberg, L
    RESPIRATORY MEDICINE, 2006, 100 (02) : 226 - 237
  • [6] SAFETY AND TOLERANCE OF REV-5901, A NOVEL 5-LIPOXYGENASE INHIBITOR, IN MAN
    TANNENBAUM, AS
    CARUSO, FS
    SERENY, N
    CAROBENE, G
    JOURNAL OF CLINICAL PHARMACOLOGY, 1985, 25 (06): : 455 - 455
  • [7] Biochemical activity, pharmacokinetics and tolerability of tepoxalin, a cyclooxygenase/5-lipoxygenase inhibitor, in man
    Depre, M
    VanHecken, A
    Verbesselt, R
    Verpooten, GA
    Arnout, J
    Brunner, F
    Jurgens, A
    Pousset, V
    Chow, A
    Baldauf, C
    Vermylen, J
    DeBroe, M
    DeSchepper, PJ
    INTERNATIONAL JOURNAL OF CLINICAL PHARMACOLOGY RESEARCH, 1996, 16 (01) : 1 - 8
  • [8] Distinct parts of leukotriene C4 synthase interact with 5-lipoxygenase and 5-lipoxygenase activating protein
    Strid, Tobias
    Svartz, Jesper
    Franck, Niclas
    Hallin, Elisabeth
    Ingelsson, Bjorn
    Soderstrom, Mats
    Hammarstrom, Sven
    BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 2009, 381 (04) : 518 - 522
  • [9] Prevalence of 5-Lipoxygenase Expression in Canine Osteosarcoma and the Effects of a Dual 5-Lipoxygenase/Cyclooxygenase Inhibitor on Osteosarcoma Cells In Vitro and In Vivo
    Goupil, R. C.
    Bushey, J. J.
    Peters-Kennedy, J.
    Wakshlag, J. J.
    VETERINARY PATHOLOGY, 2012, 49 (05) : 802 - 810
  • [10] BENEFICIAL-EFFECTS OF A 5-LIPOXYGENASE INHIBITOR IN ENDOTOXIC-SHOCK
    MATERA, G
    COOK, JA
    HENNIGAR, RA
    TEMPEL, GE
    WISE, WC
    HALUSHKA, PV
    FASEB JOURNAL, 1988, 2 (05): : A976 - A976
12345